Geodesic
Modelling of steroidindused osteoresorption in the experiment during introduction of allogenic hydroxyapatite
Vestnik Samarskogo universiteta. Estestvennonaučnaâ seriâ, no. 3 (2012), pp. 37-44 Cet article a éte moissonné depuis la source Math-Net.Ru

Voir la notice de l'article

The main spectrum of biochemical indices of blood serum in rats was investigated during steroid-induced osteoresorption. We have found the changes of bone metabolism markers under the influence of glucocortiсoids. It is established that the introduction of allogenic hydroxyapatite decrease the influence of glucocortiсoids on bone tissue.
Keywords: osteoresorption
Mots-clés : glucocorticoids, hydroxyapatite. 
@article{VSGU_2012_3_a4,
     author = {E. V. Pisareva and A. B. Sokolovskaya and M. Y. Vlasov},
     title = {Modelling of steroidindused osteoresorption in the experiment during introduction of allogenic hydroxyapatite},
     journal = {Vestnik Samarskogo universiteta. Estestvennonau\v{c}na\^a seri\^a},
     pages = {37--44},
     year = {2012},
     number = {3},
     language = {ru},
     url = {http://geodesic.mathdoc.fr/item/VSGU_2012_3_a4/}
}
TY  - JOUR
AU  - E. V. Pisareva
AU  - A. B. Sokolovskaya
AU  - M. Y. Vlasov
TI  - Modelling of steroidindused osteoresorption in the experiment during introduction of allogenic hydroxyapatite
JO  - Vestnik Samarskogo universiteta. Estestvennonaučnaâ seriâ
PY  - 2012
SP  - 37
EP  - 44
IS  - 3
UR  - http://geodesic.mathdoc.fr/item/VSGU_2012_3_a4/
LA  - ru
ID  - VSGU_2012_3_a4
ER  - 
%0 Journal Article
%A E. V. Pisareva
%A A. B. Sokolovskaya
%A M. Y. Vlasov
%T Modelling of steroidindused osteoresorption in the experiment during introduction of allogenic hydroxyapatite
%J Vestnik Samarskogo universiteta. Estestvennonaučnaâ seriâ
%D 2012
%P 37-44
%N 3
%U http://geodesic.mathdoc.fr/item/VSGU_2012_3_a4/
%G ru
%F VSGU_2012_3_a4
E. V. Pisareva; A. B. Sokolovskaya; M. Y. Vlasov. Modelling of steroidindused osteoresorption in the experiment during introduction of allogenic hydroxyapatite. Vestnik Samarskogo universiteta. Estestvennonaučnaâ seriâ, no. 3 (2012), pp. 37-44. http://geodesic.mathdoc.fr/item/VSGU_2012_3_a4/

[1] Belova K. Yu., Ershova O. B., Korshunov N. I., “Glyukokortikoidnyi osteoporoz: diagnostika i lechenie”, Rus. med. zhurn., 15:6 (2007), 546–549

[2] Graves L., Lukert B. P., “Glucocorticoid-induced osteoporosis: a clinician's perspective”, Clin. Rev. of Bone and Miner Metab., 2:2 (2006), 79–90 | DOI

[3] Reid I. R., “Editorial: glucocorticoid effects on bone”, J. Clin. Endocrinol. Metab., 83:6 (1998), 1860–1862 | DOI

[4] Silverman S. L., Lane N. E., “Glucocorticoid-induced osteoporosis”, Curr. Osteoporos Rep., 7:1 (2009), 23–26 | DOI

[5] L. T. Volova i dr., Bioimplantat dlya vosstanovleniya struktury i ob'ema kostnoi tkani, Patent na izobretenie No 2372892 (RF). Zaregistrirovan 16.06.2008

[6] Pisareva E. V., Vlasov M. Yu., “Vliyanie mineralnogo komponenta kostnoi tkani na protsessy osteorezorbtsii”, Mezhdunar. zhur. priklad. i fund. issledovanii, 2010, no. 11, 44–45

[7] E. V. Pisareva i dr., “Vliyanie allogennogo gidroksiapatita na metabolizm kostnoi tkani”, Vestnik Samarskogo gosudarstvennogo universiteta. Estestvennonauchnaya seriya, 2007, no. 8(58), 191–197

[8] Otsenka bezopasnosti nanomaterialov, metod. rekomendatsii, Federalnyi tsentr gigieny i epidemiologii, M., 2007, 57 pp.

[9] Krel A. A., Furtseva L. N., “Metody opredeleniya oksiprolina v biologicheskikh zhidkostyakh i ikh primenenie v klinicheskoi praktike”, Vopr. med. khimii, 1968, no. 6, 635–643

[10] Ermakova I. P., Pronchenko I. A., “Syvorotochnye biokhimicheskie markery v diagnostike osteoporoza”, Osteoporoz i osteopatii, 1998, no. 1, 24–26

[11] L. C. Hofbauer et al., “Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis”, Endocrinology, 140:10 (1999), 4382–4389

[12] Canalis E., “Mechanisms of glucocorticoid action on bone: implications of glucocorticoid-induced osteoporosis”, J. Clin. Endocrinol. Metab., 81:10 (1996), 344–347

[13] Ebeling P. R., “Osteoporosis in men”, N. Engl. J. Med., 358 (2008), 1474–1482 | DOI

[14] Delany A. M., Dong Y., Canalis E., “Mechanisms of glucocorticoid action in bone cells”, J. Cell Biochem., 56:3 (1994), 295–302 | DOI

[15] Arlauskas N. P., “Evolyutsiya vzglyadov na kombinirovannye preparaty kaltsiya i vitamina $\mathrm{D}$ v profilaktike i lechenii osteoporoza”, Rus. med. zhurn., 10:4 (2001), 102–112

[16] Bernard B. A., “$\mathrm{Ca}^{++}$ binding alkaline phosphotase in mecanizm of calcification”, Calc. Reg. Bone Metab. Basis and Clin. Aspects, 1987, no. 9, 413–418

[17] M. L. Malinin i dr., “Polovye razlichiya po biokhimicheskim pokazatelyam krovi u raznykh vidov laboratornykh zhivotnykh”, Izvestiya Saratovskogo universiteta, 8:1 (2008), 51–54 | MR | Zbl